Anthropic says it prioritizes trust over monetization; the company says ads inside AI chat would undermine credibility in work, health, and reasoning contexts.
Revenues jumped 30% YoY as consumers’ takeaway habits solidified.
While Chipotle struggles to get customers through the door, Taco Bell is gaining share.
The Milan Cortina Winter Olympic Games will begin on February 6 with an opening ceremony that will also kick off advertisers looking to make the most of the global event.
Consumers accept AI, not wasted effort. Seamless AI-to-human handoffs in customer service drive spend and brand affinity.
Deal talks suggest a Microsoft-style alliance to bypass Anthropic limits and deliver more customizable, differentiated AI services.
60% of younger travelers use genAI for trip planning, but high dissatisfaction with generic and wrong answers remains a hurdle.
Smaller beauty brands are shaking up the retail space by achieving faster-growing sales than their big name competitors. Independently owned and operated brands with under $300 million in revenue, called "indie beauty brands" by NielsenIQ in a new report, are rising fast online and outpacing their conglomerate competitors in-store.
This FAQ addresses the tactical and strategic questions digital media buyers and marketing leaders face.
New openings aim to improve convenience and support faster omnichannel fulfillment.
China consumer confidence shows few signs of improvement heading into the holiday period.
Closures continue, but stronger concepts are replacing weaker ones as foot traffic holds.
Installments for QuickBook invoices offers a lifeline to SMBs.
It’s betting that Google’s protocols will funnel agentic payment volume to its BNPL platform.
Amazon expands its agentic ad footprint; its new MCP server turns AI-driven advertising from experimentation into infrastructure, prioritizing controlled automation over raw API access.
The move aims to increase purchase frequency and shelf space at top retailers.
Costs will shape 2026 midterm votes, with both parties targeting insurers and pharma to lower costs. The industry has a chance to defend its role—and show real affordability gains.
But a crowded obesity market demands product differentiation, fewer side effects, and benefits beyond weight loss to reap financial gains.
The UK-based pharma giant lists its stock on NYSE even as it continues overseas manufacturing and innovation spending.
Pharma and health brands return to the Super Bowl, ditching drug pitches for brand storytelling campaigns.